Boundless Bio, Inc. Common Stock (BOLD) — Long-term Investment Intensity
Boundless Bio, Inc. Common Stock (BOLD) has a Long-term Investment Intensity of 30.8% as of December 2021. Long-term investments of $34.99 Million represent 30.8% of total assets of $113.72 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BOLD net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Boundless Bio, Inc. Common Stock Long-term Investment Intensity (2021–2021)
This chart shows how Boundless Bio, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the intensity stands at 30.8%, reflecting long-term investments of $34.99 Million against total assets of $113.72 Million USD. Also explore how large is Boundless Bio, Inc. Common Stock's balance sheet for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Boundless Bio, Inc. Common Stock (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Boundless Bio, Inc. Common Stock from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Boundless Bio, Inc. Common Stock market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 30.8% | $34.99 Million | $113.72 Million | — |